Weight Loss Drugs Linked to Brain Risk | Dayton News

New research reveals a rare but serious brain condition, Wernicke encephalopathy, linked to popular weight-loss drugs like Ozempic and Wegovy. Caused by severe vitamin B1 (thiamine) deficiency, it can lead to confusion, balance issues, and eye abnormalities—potentially fatal if untreated. Fifteen cases were identified in 2023–2024 among patients on GLP-1 meds, often coinciding with poor appetite, vomiting, or rapid weight loss. Experts suspect the drugs suppress hunger, reducing intake of B1-rich foods. Doctors are now monitoring users closely as this emerging risk underscores that even effective medications carry potential side effects—and open communication with your healthcare provider is key. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/3fc5eb940f711d0e